Comparison of speed-dependent time, force and spatial parameters between Franches-Montagnes and European Warmblood horses walking and trotting on a treadmill.

Speed alterations affect many gait analysis parameters. How horses adapt to speed is relevant in many equestrian disciplines and may differ between breeds. This study described changes in gait parameters in 38 Warmblood (WB) and 24 Franches-Montagnes (FM) horses subjected to an incremental speed test at walk (1.35-2.05 m/s) and trot (3.25-5.5 m/s). Time, force and spatial parameters of each limb were measured with an instrumented treadmill and analysed with regression analysis using speed as the independent variable. With higher speeds, stride rate, length, over-tracking distance and vertical ground reaction forces increased while the impulses decreased. The parameters followed the same linear or polynomial regression curves independent of breed, while the slope (linear) or incurvation (polynomial) often differed significantly between breeds. Some differences between the breeds were associated with height and speed (e.g. stride length at walk), and would disappear when scaling the data. The main differences between the breeds seem to stem from the movement of the hind limbs, with the FM obtaining long over-tracking distances despite the shorter height at withers. Some parameters relevant to gait quality could be improved in the FM to resemble WB movement by strict selection using objective measurements systems.

Governing health data across changing contexts: A focus group study of citizen's views in England, Iceland, and Sweden.

BACKGROUND: The governance structures associated with health data are evolving in response to advances in digital technologies that enable new ways of capturing, using, and sharing different types of data. Increasingly, health data moves between different contexts such as from healthcare to research, or to commerce and marketing. Crossing these contextual boundaries has the potential to violate societal expectations about the appropriate use of health data and diminish public trust. Understanding citizens' views on the acceptability of and preferences for data use in different contexts is essential for developing information governance policies in these new contexts. METHODS: Focus group design presenting data sharing scenarios in England, Iceland, and Sweden. RESULTS: Seventy-one participants were recruited. Participants supported the need for data to help understand the observable world, improve medical research, the quality of public services, and to benefit society. However, participants consistently identified the lack of information, transparency and control as barriers to trusting organisations to use data in a way that they considered appropriate. There was considerable support for fair and transparent data sharing practices where all parties benefitted. CONCLUSION: Data governance policy should involve all stakeholders' perspectives on an ongoing basis, to inform and implement changes to health data sharing practices that accord with stakeholder views. The Findings showed that (1) data should be used for ethical purposes even when there was commercial interest; (2) data subjects and/or public institutions that provide and share data should also receive benefits from the sharing of data; (3) third parties use of data requires greater transparency and accountability than currently exists, (4) there should be greater information provided to empower data subjects.